Bausch Health Companies Inc.
A Canadian healthcare company behind some of the world's best-known eye and skin products, Bausch Health makes contact lenses, dry-eye treatments, and the Thermage skin-tightening device, while its Salix arm sells the gut medicine Xifaxan. Its roots trace to an 1853 Rochester optical shop founded by John Jacob Bausch, who borrowed money from friend Henry Lomb to get the business going. The company began as ICN Pharmaceuticals in 1959 and later renamed itself after the famous lens maker it acquired — the firm that brought America its first mass-produced soft contact lenses in 1971.
Granted 1.36M · Bought 56.73M · Sold 7.41M
Bought 2.50M
Sold 21.59M
Granted 81.1K · Bought 2.46M · Sold 11.86M
Granted 21.7K
Granted 7.6K
Bought 948.4K · Sold 948.4K
Bought 460.0K · Sold 4.20M
Granted 5.0K
Granted 57.2K
Granted 3.8K · Bought 1.35M
Granted 4.19M · Bought 25.4K
Granted 5.23M · Bought 339.9K · Sold 1.30M
Granted 3.67M · Bought 322.0K
Granted 1.6K · Bought 3.00M
Granted 791.5K
Granted 162.1K
Granted 973.5K · Sold 61.7K
Granted 517.6K
Granted 513.8K · Bought 20.8K
Granted 440.6K
Granted 164.7K · Bought 228.8K
Granted 508.9K · Bought 49.0K
Granted 466.8K · Bought 30.7K · Sold 156.5K
Granted 372.1K · Bought 100.6K
Granted 324.6K · Sold 11.0K
Granted 311.5K
Granted 282.2K
Granted 991.6K · Bought 6.2K · Sold 516.9K
Granted 179.1K · Bought 60.0K
Granted 225.3K
Granted 231.2K
Granted 220.3K
Granted 215.2K
Granted 465.2K · Bought 4.4K · Sold 148.5K
Granted 150.0K · Bought 11.5K
Granted 157.9K · Bought 7.5K
Granted 155.6K
Granted 8.2K · Bought 7.5K
Granted 175.3K · Bought 15.1K · Sold 40.0K
Granted 135.6K
Granted 102.7K
Granted 164.8K · Bought 19.2K
Granted 712.0K · Bought 15.0K · Sold 242.7K
Granted 119.7K · Bought 4.0K
Granted 134.5K · Sold 17.0K
Granted 212.7K · Sold 110.0K
Granted 101.4K
Granted 106.4K · Sold 14.5K
Granted 155.9K · Bought 15.0K
Granted 135.6K · Sold 40.4K
Granted 126.3K · Sold 21.3K
Granted 275.1K · Sold 9.9K
Granted 90.2K
Granted 58.5K · Sold 4
Granted 81.1K
Granted 27.0K · Bought 16.5K
Granted 76.0K
Granted 670.2K · Sold 883.0K
Granted 73.2K
Granted 66.7K · Sold 48.0K
Granted 12.5K · Bought 20.0K
Granted 3.0K · Bought 51.0K
Granted 45.9K
Granted 35.1K · Bought 2.5K
Granted 43.2K
Granted 169.2K · Sold 169.2K
Granted 4.5K
Granted 75.0K · Sold 75.0K
Granted 65.0K · Sold 16.1K
Granted 25.2K · Bought 7.5K
Granted 4.6K
Granted 18.4K · Bought 4.6K
Granted 15.2K · Sold 10.8K
Granted 4.4K
Granted 20.0K · Sold 20.0K
Granted 5.0K
Granted 40.0K · Sold 40.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Paulson JohnDirector · 69 transactions | — | 73.67M | 1.36M | 56.73M | 7.41M |
| Paulson & Co. Inc.10% owner · 1 transaction | — | 73.26M | — | 2.50M | — |
| Ackman William A +2 co-filersDirector · 2 transactions | — | 39.71Mas of Mar 2017 | — | — | 21.59M |
| VA Partners I, LLC +5 co-filersReporting owner · 30 transactions | — | 35.15Mas of Jun 2012 | 81.1K | 2.46M | 11.86M |
| Hale David Robert +8 co-filersReporting owner · 4 transactions | — | 18.06Mas of May 2020 | 21.7K | — | — |
| Hale David Robert +7 co-filersReporting owner · 1 transaction | — | 17.96Mas of May 2021 | 7.6K | — | — |
| VA Partners I, LLC +7 co-filersReporting owner · 3 transactions | — | 17.93Mas of Jun 2020 | — | 948.4K | 948.4K |
| Ubben Jeffrey W +7 co-filersReporting owner · 10 transactions | — | 17.61Mas of Jun 2015 | — | 460.0K | 4.20M |
| Morfit G Mason +6 co-filersReporting owner · 3 transactions | — | 17.58Mas of Jun 2013 | 5.0K | — | — |
| Hale David Robert +7 co-filersReporting owner · 7 transactions | — | 16.99Mas of May 2018 | 57.2K | — | — |
| Morfit G Mason +7 co-filersReporting owner · 3 transactions | — | 15.00Mas of May 2016 | 3.8K | 1.35M | — |
| Appio ThomasChief Executive Officer, Director · 59 transactions | — | 3.45M | 4.19M | 25.4K | — |
| Pearson J. MichaelChief Executive Officer, Director · 18 transactions | — | 2.04Mas of Nov 2015 | 5.23M | 339.9K | 1.30M |
| Papa Joseph CDirector · 38 transactions | — | 1.21Mas of May 2022 | 3.67M | 322.0K | — |
| VA Partners I, LLC +6 co-filersReporting owner · 3 transactions | — | 1.06Mas of Mar 2017 | 1.6K | 3.00M | — |
| Charhon Jean-JacquesEVP, CFO · 5 transactions | — | 706.5K | 791.5K | — | — |
| Kellen AriEVP, Company Group Chairman · 5 transactions | — | 630.8Kas of Dec 2016 | 162.1K | — | — |
| Carson SeanaEVP, General Counsel · 44 transactions | — | 616.8K | 973.5K | — | 61.7K |
| Vadaketh Tom GeorgeEVP, Chief Financial Officer · 5 transactions | — | 564.9Kas of Sep 2023 | 517.6K | — | — |
| Rosiello Robert L.EVP, Corp Dev & Strategy · 11 transactions | — | 517.7Kas of Dec 2016 | 513.8K | 20.8K | — |
| Lenar Aimee J.EVP, US Pharma · 6 transactions | — | 400.3K | 440.6K | — | — |
| De Schutter Richard UDirector · 48 transactions | — | 387.2Kas of Apr 2023 | 164.7K | 228.8K | — |
| Herendeen PaulEVP and CFO · 21 transactions | — | 386.6Kas of Mar 2021 | 508.9K | 49.0K | — |
| Humphries William D.President, Ortho-Dermatologics · 22 transactions | — | 349.1Kas of Dec 2020 | 466.8K | 30.7K | 156.5K |
| Schiller Howard BradleyChairman and CEO, Director · 31 transactions | — | 336.8Kas of Feb 2016 | 372.1K | 100.6K | — |
| Wechsler Amy BDirector · 52 transactions | — | 313.6K | 324.6K | — | 11.0K |
| Power Robert NDirector · 19 transactions | — | 300.6K | 311.5K | — | — |
| Kavanagh Sarah BDirector · 11 transactions | — | 282.2K | 282.2K | — | — |
| De Silva RajivPresident and COO · 29 transactions | — | 259.8Kas of Jan 2013 | 991.6K | 6.2K | 516.9K |
| Miller Steven DDirector · 16 transactions | — | 239.2Kas of May 2025 | 179.1K | 60.0K | — |
| Robertson Russel CDirector · 40 transactions | — | 225.3Kas of Mar 2024 | 225.3K | — | — |
| Melas Kyriazi TheoDirector · 29 transactions | — | 223.1Kas of May 2016 | 231.2K | — | — |
| Icahn BrettDirector · 24 transactions | — | 220.3Kas of Jun 2025 | 220.3K | — | — |
| Barresi John SSVP, Controller & CAO · 12 transactions | — | 197.4Kas of Feb 2025 | 215.2K | — | — |
| Ackermann ChristinaEVP AND GENERAL COUNSEL · 38 transactions | — | 162.2Kas of Mar 2022 | 465.2K | 4.4K | 148.5K |
| Ross Thomas W. Sr.Director · 12 transactions | — | 161.5Kas of May 2023 | 150.0K | 11.5K | — |
| Whitaker Anne ClemEVP, Company Group Chairman · 7 transactions | — | 158.5Kas of Dec 2016 | 157.9K | 7.5K | — |
| Mulligan RichardDirector · 5 transactions | — | 155.6Kas of May 2025 | 155.6K | — | — |
| Loberg Philip Walden JrEVP, Interim CFO · 3 transactions | — | 145.1Kas of Jul 2011 | 8.2K | 7.5K | — |
| Provencio Norma AnnDirector · 53 transactions | — | 144.9Kas of May 2016 | 175.3K | 15.1K | 40.0K |
| Garcia Christian ADirector · 3 transactions | — | 135.6K | 135.6K | — | — |
| Mulligan Margaret JeanEVP, CFO · 2 transactions | — | 130.7Kas of Nov 2010 | 102.7K | — | — |
| Stolz Brian M.EVP, Administration & CHCO · 41 transactions | — | 125.3Kas of Jun 2015 | 164.8K | 19.2K | — |
| Chai-Onn Robert RoswellEVP, CLO, General Counsel · 39 transactions | — | 124.8Kas of May 2016 | 712.0K | 15.0K | 242.7K |
| Karabelas Argeris NDirector · 8 transactions | — | 123.7Kas of Jun 2022 | 119.7K | 4.0K | — |
| Eldessouky SamEVP & Chief Financial Officer · 28 transactions | — | 119.5Kas of Mar 2022 | 134.5K | — | 17.0K |
| Durham Mark AndrewSVP Human Resources · 7 transactions | — | 111.6Kas of May 2011 | 212.7K | — | 110.0K |
| Weldon RyanEVP, Company Group Chairman · 15 transactions | — | 109.1Kas of Apr 2014 | 101.4K | — | — |
| Spurr RobertPresident, U.S. Businesses · 20 transactions | — | 99.1Kas of May 2022 | 106.4K | — | 14.5K |
| Kornwasser LaizerEVP, Company Group Chairman · 21 transactions | — | 98.8Kas of Apr 2015 | 155.9K | 15.0K | — |
| Lee Frank D.Director · 5 transactions | — | 95.2K | 135.6K | — | 40.4K |
| Gordon Joseph FPres&Co-Head Bausch&Lomb/Int'l · 24 transactions | — | 93.1Kas of Mar 2022 | 126.3K | — | 21.3K |
| Ingram Robert AlexanderDirector · 26 transactions | — | 92.0Kas of Mar 2017 | 275.1K | — | 9.9K |
| Leung SandraDirector · 5 transactions | — | 90.2K | 90.2K | — | — |
| Masterson Richard KevinPres. & COO, Valeant Intl. BB · 7 transactions | — | 89.5Kas of May 2012 | 58.5K | — | 4 |
| Morfit G MasonDirector · 7 transactions | — | 81.1Kas of Jun 2012 | 81.1K | — | — |
| Farmer Ronald HaroldDirector · 43 transactions | — | 77.9Kas of May 2016 | 27.0K | 16.5K | — |
| Goettler MichaelDirector · 2 transactions | — | 76.0K | 76.0K | — | — |
| Wells William McDowallDirector · 9 transactions | — | 75.0Kas of Dec 2010 | 670.2K | — | 883.0K |
| Lee Steven HyosigSVP, Controller & CAO · 2 transactions | — | 73.2K | 73.2K | — | — |
| Mirovsky PavelEVP, Pres. & GM Valeant EMENA · 11 transactions | — | 69.5Kas of Jun 2015 | 66.7K | — | 48.0K |
| Paul Laurence EDirector · 8 transactions | — | 56.2Kas of Jun 2012 | 12.5K | 20.0K | — |
| Hassan FredDirector · 2 transactions | — | 54.0Kas of Aug 2013 | 3.0K | 51.0K | — |
| Roberts EiryDirector · 1 transaction | — | 45.9K | 45.9K | — | — |
| Von Eschenbach Andrew C.Director · 6 transactions | — | 38.6Kas of Aug 2021 | 35.1K | 2.5K | — |
| Eshelman Fredric NDirector · 5 transactions | — | 38.3Kas of May 2017 | 43.2K | — | — |
| Jorn DeboraEVP, Company Group Chairman · 1 transaction | — | 34.8Kas of Nov 2015 | — | — | — |
| Chouinard MichelCOO, Biovail Labs.Intl SRL · 12 transactions | — | 34.7Kas of Nov 2010 | 169.2K | — | 169.2K |
| Lonner AndersDirector · 3 transactions | — | 29.9Kas of May 2015 | 4.5K | — | — |
| Squires Douglas John PaulDirector · 2 transactions | — | 29.7Kas of Jun 2010 | 75.0K | — | 75.0K |
| Hall SusanGlobal Head of R&D · 10 transactions | — | 27.6Kas of Jul 2013 | 65.0K | — | 16.1K |
| Stevenson Katharine BerghuisDirector · 12 transactions | — | 24.7Kas of May 2015 | 25.2K | 7.5K | — |
| Munsch FrederickSVP, Controller and CAO · 7 transactions | — | 22.4Kas of May 2022 | 4.6K | — | — |
| Segal Lloyd MitchellDirector · 15 transactions | — | 21.8Kas of Jun 2013 | 18.4K | 4.6K | — |
| McKenna Mark C.President, Salix · 6 transactions | — | 20.8Kas of Aug 2019 | 15.2K | — | 10.8K |
| Van Every Michael RobertDirector · 1 transaction | — | 6.4Kas of May 2011 | 4.4K | — | — |
| Mayer ChristineSVP, BTA Pharmaceuticals, Inc. · 7 transactions | — | 6.0Kas of Aug 2010 | 20.0K | — | 20.0K |
| Goggins Colleen ADirector · 3 transactions | — | 5.0Kas of May 2015 | 5.0K | — | — |
| Fibiger Hans ChristianChief Scientific Officer · 4 transactions | — | 0as of Mar 2010 | 40.0K | — | 40.0K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +18.87M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.